Abstract

An antimicrobial compound, highly effective against multidrug-resistant (MDR) bacteria, purified from a Streptomyces strain was identified as manumycin. The minimal inhibitory concentrations (MICs) of manumycin against 8 different strains of methicillin-resistant Staphylococcus aureus (MRSA) were ranged 2 to 32 μg/ml. Similarly, MICs of manumycin against 4 vancomycin-resistant enterococci (VRE) strains were ranged 8 to 32 μg/ml while it remained ineffective against 4 other VRE strains. Compared to vancomycin, manumycin provided slightly weaker activity against MRSA strains but stronger activity against 4 VRE strains. This is the first report of antagonistic effect of manumycin against MDR pathogens. Keywords : Manumycin, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE) African Journal of Biotechnology Vol. 12(17), pp. 2249-2253

Highlights

  • Manumycin is a group of small and discrete class of antibiotics which consist of almost a dozen secondary metabolites produced exclusively by Streptomyces (Sattler et al, 1998)

  • Highly effective against multidrug-resistant (MDR) bacteria, purified from a Streptomyces strain was identified as manumycin

  • minimal inhibitory concentrations (MICs) of manumycin against 4 vancomycin-resistant enterococci (VRE) strains were ranged 8 to 32 μg/ml while it remained ineffective against 4 other VRE strains

Read more

Summary

Introduction

Manumycin is a group of small and discrete class of antibiotics which consist of almost a dozen secondary metabolites produced exclusively by Streptomyces (Sattler et al, 1998). Manumycin was first reported by Buzzetti and coworkers in 1963. Its chemical structure has two unsaturated carbon chains, so called m-C7N and C5N unit, which are linked in meta-fashion to unique multifunctional six-membered ring. Manumycin-type compounds derived from the m-C7N unit vary in its stereochemistry and the nature of the oxygen substituent.

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.